Onsemble Welcomes Dana-Farber / Harvard Cancer Center
An extensive search for an integrated clinical research management system came to an end in February when Dana-Farber/Harvard Cancer Center (DF/HCC) selected the OnCore(r) system.
Read more...
University of Alabama at Birmingham (UAB) Comprehensive Cancer Center Selects OnCore(r) as its Clinical Research Informatics PlatformWhen the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center decided to enhance their clinical research infrastructure, comprehensive functionality and a reputation for customer service contributed to their decision to select the OnCore(r) clinical research management system from PercipEnz Technologies, Inc. in December. OnCore® Version 10.0 Brings it all Together for the Clinical Research Enterprise
MADISON, Wis. (April 5, 2010) - This year's release of the OnCore Clinical and Translational Research Software, Version 10.0, represents thousands of hours of development effort and incorporates work done in eight collaborative projects with research organizations around the country.
Read more...
Rutgers-Cleveland Clinic Consortium of AFIRM Selects OnCore® to Support its Collaborative Clinical Research on Regenerative TherapiesMADISON, Wis. (November 4, 2009) -- When evaluating what was needed to support a widely distributed consortium comprised of 15 organizations across the country who are conducting cutting-edge collaborative clinical research, the Rutgers-Cleveland Clinic Consortium (RCCC) selected the OnCore Clinical Research Management system (OnCore-CRM) to administer their studies and coordinate the group's efforts. University of Florida Shands Cancer Center Achieves Goal and Goes Live with OnCore in Under Four MonthsMADISON, Wis. (October 1, 2009) - The University of Florida Shands Cancer Center (UFSCC) set an aggressive timeline for their implementation of a new clinical research management system and, in just over three months, they met it. Back in June, the cancer clinical trials office began migrating data from their legacy system and rolling-out the OnCore system for clinical research management (OnCore-CRM). On Wednesday, September 23rd, the new OnCore users celebrated the go live of the new system with cake. Improving Research Efficiencies through Collaboration was theme of Onsemble 2009 Fall ConferenceMADISON, Wis. (September 18, 2009) – There just never seems to be enough time at the semi-annual Onsemble conferences. With a whirlwind of activity, the eighth face-to-face gathering of the OnCore community was no exception for the 117 people who attended. Member and guest contributions are critical to the success of all Onsemble conferences. For this event, representatives from 16 cancer centers sat on the Program Committee, which began working in March to plan the agenda. At the conference, presentations were delivered by over 22 member and special-guest speakers. Slide presentations, videos and other materials from the conference are now available for download from the Onsemble.net website. University of Florida Shands Cancer Center Selects OnCore to Support it's Collaborative Research GoalsMADISON, Wis. (July 13, 2009) – An institutional goal to develop collaborative partnerships with other research organizations was a key factor in the recent decision by the University of Florida Shands Cancer Center (UFSCC) to select OnCore® products in support of their clinical and translational research informatics needs. With the signing of the contract, the UFSCC has become the 25th cancer center to adopt the OnCore platform. OnCore 9.0 Released"Top 5" Priorities and Collaborative Initiatives Cornerstones of Product DevelopmentThe latest version of the OnCore(r) clinical research management system epitomizes the collaborative development process of software developer, PercipEnz Technologies, Inc. Released April 27th, OnCore 9.0 not only sports a sleek new user interface but also incorporates over 200 enhancement requests provided by 20 research organizations. "This version of OnCore brings together enhancements that have been under development for almost a year through multiple collaborative initiatives," said Tony O'Hare, PhD, chief scientific officer at PercipEnz. Onsemble.net has been upgraded!As you navigate around this site, you will find several enhancements with more on the way! This is just the first step. You will need to reset your password to begin using the updated site. Simply click the "Forgot your password?" link and it will send you a "token" by email that you can use to reset your password. Once that is done, you have instant access to the site 24/7. West Virginia University Mary Babb Randolph Cancer Center Selects OnCore® as it’s Clinical Research Informatics PlatformMADISON, Wis. (April 14, 2009) – On April 1st, PercipEnz received the signed contract for OnCore from the West Virginia University Mary Babb Randolph Cancer Center (MBRCC). With the signing of the contract for the OnCore Clinical Research Management system (OnCore CRM), the MBRCC has become the 24th cancer center to adopt the OnCore platform in support of its clinical research informatics needs. OnCore is the most widely adopted informatics platform among cancer centers nationwide and is used by one out of every four NCI-designated cancer centers. The MBRCC is West Virginia’s most comprehensive cancer treatment, research and education facility. The center offers a multidisciplinary team approach and state of the art technologies and treatments, as well as the latest clinical trials and a variety of education and prevention outreach programs. The Cancer Center, operated by WVU Hospitals, houses the NCI's Mid-Atlantic Cancer Information Service, the Betty Puskar Breast Care Center and the Blood and Marrow Transplant / Hematologic Malignancy Program. For more information, visit the MBRCC website at: www.hsc.wvu.edu/mbrcc/ The OnCore system is the flagship product of PercipEnz Technologies, Inc., a software development company specializing in clinical and translational research informatics for midsized to large organizations. Winship Cancer Institute Earns Prestigious NCI Cancer Center DesignationThe Winship Cancer Institute of Emory University's Woodruff Health Sciences Center has earned the prestigious National Cancer Institute Cancer Center Designation. With this distinction, Emory Winship realizes a decades-long goal and joins the ranks of this nation's elite cancer research and treatment facilities. Winship's NCI designation means patients throughout Emory Healthcare and its affiliates, including the Georgia Cancer Center of Excellence at Grady and the Atlanta VA Medical Center, will realize greater access to new clinical trials and technologies that are available only through NCI-designated cancer centers. In addition, the designation will enable Emory to continue to develop research initiatives that will result in new therapies for patients throughout Georgia, the region, and the United States. Emory's Winship Cancer Institute serves as a coordinating center for an array of cancer research, treatment and other programs throughout Emory and partnering institutions, among them Children's Healthcare of Atlanta, Georgia Tech, the U.S. Centers for Disease Control and Prevention, and the American Cancer Society. http://www.emory.edu/home/news/releases/2009/04/winships-nci-cancer-center-designation.html Cincinnati Children's Hospital Medical Center Goes Live with OnCoreThe Center's Oncology Department Started Using the System on March 25thMADISON, Wis. (April 3, 2009) -- Cincinnati Children's Hospital Medical Center (CCHMC) went live March 25th with the implementation of OnCore in their Oncology department. University of California, San Francisco Helen Diller Family Comprehensive Cancer Center has Selected OnCoreMADISON, Wis. (March 24, 2009) — After an evaluation of 11 systems, the OnCore® clinical research management system stood out as the system that would work best for the Helen Diller Family Comprehensive Cancer Center & Cancer Research Institute (HDFCCC) at the University of California, San Francisco (UCSF). University of California - Irvine Chao Family Comprehensive Cancer Center Selects OnCoreMADISON, Wis. (February 26, 2009) - With the signing of their contract for the OnCore® clinical research management system in January, the Chao Family Comprehensive Cancer Center (CFCCC) of the Unversity of California-Irvine became the 22nd cancer center to adopt the OnCore platform in support of its clinical research informatics needs. Center director, Frank L. Meyskens, Jr., M.D., announced last week that the CFCCC has purchased both the OnCore Clinical Research Management system (OnCore CRM) as well as the OnCore Biospecimen Management system (OnCore-BSM). Crescendo, the Clinical and Translational Research Exchange, is LaunchedCoinciding with the 9th anniversary celebration for the company, PercipEnz Technologies, Inc. announces the launch of Crescendo(tm), the company's suite of services for clinical and translation research data exchange. The website, located at www.CrescendoEx.com, provides descriptions of the available services and acts as an access point for some of these. Catering to the needs of the cancer centers and multi-disciplinary research organizations that use PercipEnz's OnCore® software platform, the Crescendo exchange fosters collaboration among, and leverages the collective expertise of, these world-class institutions. OnCore® System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research![]() MADISON, WI -- A proven and widely adopted research informatics platform, OnCore®, achieved another milestone this fall with the implementation at a world-class multidisciplinary research organization. At the end of September, the University of Wisconsin Institute for Clinical and Translational Research (UWICTR) began using OnCore to handle their clinical research data collection and administration needs. OnCore is the flagship product of PercipEnz Technologies, Inc., a software development company specializing in clinical and translational research informatics for midsized to large organizations. to the large, multi-disciplinary, multi-departmental, clinical and translational research enterprise. "We began working closely with the University of Wisconsin almost two years ago as they were formulating their plan to assemble the new institute's informatics system," says Tony O'Hare, PhD, chief scientific officer at PercipEnz. "While we had several years of experience supporting the complex informatics needs of cancer centers, the scope of the UWICTR project was an excellent opportunity to demonstrate the power of OnCore beyond cancer research." |
|
|

Onsemble News
